Skip to content

H.R. 7871 · 119th Congress (2025–2027)

MVP Act

This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. (Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.)

The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes.

Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare & Medicaid Services to issue guidance on how state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements.

Show official title

To amend title XIX of the Social Security Act to codify value-based purchasing arrangements under the Medicaid program and reforms related to price reporting under such arrangements, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 7871’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Brett Guthrie (R-KY-2)
Cosponsors
18 cosponsors

5 original · 13 later

11 R · 7 D

  1. Rep. Jake Auchincloss (D-MA-4)· Original · Mar 9, 2026
  2. Rep. Donald G. Davis (D-NC-1)· Original · Mar 9, 2026
  3. Rep. John Joyce (R-PA-13)· Original · Mar 9, 2026
  4. Rep. Mariannette Miller-Meeks (R-IA-1)· Original · Mar 9, 2026
  5. Rep. Scott H. Peters (D-CA-50)· Original · Mar 9, 2026
  6. Rep. Glenn Ivey (D-MD-4)· Later · May 11, 2026
  7. Rep. Kevin Mullin (D-CA-15)· Later · May 11, 2026
  8. Rep. Beth Van Duyne (R-TX-24)· Later · May 11, 2026
  9. Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · May 12, 2026
  10. Rep. Neal P. Dunn (R-FL-2)· Later · May 12, 2026
  11. Rep. Kat Cammack (R-FL-3)· Later · May 20, 2026
  12. Rep. Ted Lieu (D-CA-36)· Later · May 26, 2026
  13. Rep. Troy Balderson (R-OH-12)· Later · Jun 8, 2026
  14. Rep. Mike Kelly (R-PA-16)· Later · Jun 8, 2026
  15. Rep. Daniel Meuser (R-PA-9)· Later · Jun 8, 2026
  16. Rep. Gus M. Bilirakis (R-FL-12)· Later · Jun 30, 2026
  17. Rep. Joe Wilson (R-SC-2)· Later · Jul 21, 2026
  18. Rep. Jared Huffman (D-CA-2)· Later · Nov 11, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Mar 9, 2026
  2. HouseWays and MeansReferred Mar 9, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. MVP Act

    Display title, Short title · Introduced in House

  2. Medicaid VBPs for Patients Act

    Short title · Introduced in House

  3. To amend title XIX of the Social Security Act to codify value-based purchasing arrangements under the Medicaid program and reforms related to price reporting under such arrangements, and for other purposes.

    Official title · Introduced in House